341 related articles for article (PubMed ID: 18422920)
1. Preanalytical conditions for broth microdilution antifungal susceptibility of Microsporum spp.
Biancalana FS; Telles PF; Lyra L; Schreiber AZ
Mycoses; 2008 Jul; 51(4):313-7. PubMed ID: 18422920
[TBL] [Abstract][Full Text] [Related]
2. Standardization of hyphal growth inhibition rate as a means of evaluating Microsporum spp. in vitro susceptibility to terbinafine, griseofulvin, and ciclopiroxolamine.
Biancalana FS; Lyra L; Moretti ML; Kamei K; Schreiber AZ
Mycopathologia; 2011 Oct; 172(4):279-85. PubMed ID: 21611866
[TBL] [Abstract][Full Text] [Related]
3. In vitro methods for antifungal susceptibility testing of Trichophyton spp.
Barros ME; Santos Dde A; Hamdan JS
Mycol Res; 2006 Nov; 110(Pt 11):1355-60. PubMed ID: 17070026
[TBL] [Abstract][Full Text] [Related]
4. In vitro activity of aminosterols against dermatophytes.
Coulibaly O; Alhanout K; L'Ollivier C; Brunel JM; Thera MA; Djimdé AA; Doumbo OK; Piarroux R; Ranque S
Med Mycol; 2013 Apr; 51(3):309-12. PubMed ID: 22998181
[TBL] [Abstract][Full Text] [Related]
5. In vitro antifungal susceptibility patterns of dermatophyte strains causing tinea unguium.
Sarifakioglu E; Seçkin D; Demirbilek M; Can F
Clin Exp Dermatol; 2007 Nov; 32(6):675-9. PubMed ID: 17714532
[TBL] [Abstract][Full Text] [Related]
6. In vitro evaluation of griseofulvin against clinical isolates of dermatophytes from Isfahan.
Chadeganipour M; Nilipour S; Havaei A
Mycoses; 2004 Dec; 47(11-12):503-7. PubMed ID: 15601457
[TBL] [Abstract][Full Text] [Related]
7. Susceptibility of dermatophyte isolates obtained from a large worldwide terbinafine tinea capitis clinical trial.
Ghannoum MA; Wraith LA; Cai B; Nyirady J; Isham N
Br J Dermatol; 2008 Sep; 159(3):711-3. PubMed ID: 18510668
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of broth microdilution antifungal susceptibility testing conditions for Trichophyton rubrum.
Santos DA; Hamdan JS
J Clin Microbiol; 2005 Apr; 43(4):1917-20. PubMed ID: 15815018
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of Citrus bergamia (bergamot) oil against clinical isolates of dermatophytes.
Sanguinetti M; Posteraro B; Romano L; Battaglia F; Lopizzo T; De Carolis E; Fadda G
J Antimicrob Chemother; 2007 Feb; 59(2):305-8. PubMed ID: 17118937
[TBL] [Abstract][Full Text] [Related]
10. Tinea capitis caused by Microsporum canis treated with terbinafine.
Aste N; Pau M
Mycoses; 2004 Oct; 47(9-10):428-30. PubMed ID: 15504128
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial susceptibility testing of dermatophytes--comparison of the agar macrodilution and broth microdilution tests.
Niewerth M; Splanemann V; Korting HC; Ring J; Abeck D
Chemotherapy; 1998; 44(1):31-5. PubMed ID: 9444406
[TBL] [Abstract][Full Text] [Related]
12. In vitro susceptibility testing of dermatophytes: comparison of disk diffusion and reference broth dilution methods.
Karaca N; Koç AN
Diagn Microbiol Infect Dis; 2004 Apr; 48(4):259-64. PubMed ID: 15062918
[TBL] [Abstract][Full Text] [Related]
13. Terbinafine susceptibility patterns for onychomycosis-causative dermatophytes and Scopulariopsis brevicaulis.
Carrillo-Muñoz AJ; Giusiano G; Cárdenes D; Hernández-Molina JM; Eraso E; Quindós G; Guardia C; del Valle O; Tur-Tur C; Guarro J
Int J Antimicrob Agents; 2008 Jun; 31(6):540-3. PubMed ID: 18367383
[TBL] [Abstract][Full Text] [Related]
14. In vitro antifungal susceptibility testing of filamentous fungi with Sensititre Yeast One.
Carrillo-Muñoz AJ; Quindós G; Ruesga M; del Valle O; Pemán J; Cantón E; Hernández-Molina JM; Santos P
Mycoses; 2006 Jul; 49(4):293-7. PubMed ID: 16784443
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of panomycocin, a novel exo-beta-1,3-glucanase isolated from Pichia anomala NCYC 434, against dermatophytes.
Izgü F; Altinbay D; Türeli AE
Mycoses; 2007 Jan; 50(1):31-4. PubMed ID: 17302745
[TBL] [Abstract][Full Text] [Related]
16. The best type of inoculum for testing the antifungal drug susceptibility of Microsporum canis: In vivo and in vitro results.
Aneke CI; Rhimi W; Pellicoro C; Cantacessi C; Otranto D; Cafarchia C
Mycoses; 2020 Jul; 63(7):711-716. PubMed ID: 32299129
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of microdilution and disk diffusion methods for antifungal susceptibility testing of dermatophytes.
Singh J; Zaman M; Gupta AK
Med Mycol; 2007 Nov; 45(7):595-602. PubMed ID: 17885958
[TBL] [Abstract][Full Text] [Related]
18. Species distribution and antifungal susceptibilities of dermatophytes during a one year period at a university hospital in Turkey.
Ozkutuk A; Ergon C; Yulug N
Mycoses; 2007 Mar; 50(2):125-9. PubMed ID: 17305776
[TBL] [Abstract][Full Text] [Related]
19. In vitro susceptibility of Microsporum canis and other dermatophyte isolates from veterinary infections during therapy with terbinafine or griseofulvin.
Hofbauer B; Leitner I; Ryder NS
Med Mycol; 2002 Apr; 40(2):179-83. PubMed ID: 12058731
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity of Phytolacca dodecandra (Endod) against dermatophytes.
Woldeamanuel Y; Abate G; Chryssanthou E
Ethiop Med J; 2005 Jan; 43(1):31-4. PubMed ID: 16370528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
